Tag: MENA

Posted on

Expereo acquires Breeze Networks, further enhancing its SD-WAN/SASE practice and presence in the UK market

AMSTERDAM, Aug. 15, 2022 (GLOBE NEWSWIRE) — The world’s leading provider of managed network solutions, Expereo, has announced the acquisition of Breeze Networks, a managed service provider of SD-WAN/SASE technologies. The acquisition fuels Expereo’s growth trajectory, further enhancing its SD-WAN/SASE practice, building on its expanding range of services to manage SD-WAN solutions at scale to partners and multinational enterprise customers across the globe.

This latest acquisition solidifies Expereo’s ambition to complement its managed network solutions with world-class advisory practice providing guidance to organizations on their global transformation to software-defined and internet-based networking. With the full support of majority investor Vitruvian Partners and minority investor Apax Partners SAS, Expereo intends to continue its acquisition strategy.

Breeze Networks is a managed service provider of cloud-based (SD-WAN) network connectivity and security solutions for enterprises and government agencies. An innovative and flexible network integrator, Breeze sources and manages the best SD-WAN networking and security solutions on the market.

As part of the acquisition, Expereo welcomes Matthew Lea, CTO of Breeze Networks as Technical Portfolio Lead. His expertise will be a great addition to the knowledge base of Expereo’s Technical team, led by CTO, Kristaps Petrovskis. Lea will drive Expereo’s expansion plans for its SD-WAN/SASE practice, solidifying the company’s presence in the UK market in his new role at Expereo.

“This acquisition comes at an exciting time, as we expand our SD-WAN services to address the growing need for agile, cost-effective cloud access and global network solutions in the market. With our shared vision to simplify global connectivity and provide world-class customer experience, the expertise of the team of professionals behind Breeze Networks will contribute great value as we join forces,” comments Irwin Fouwels, CEO of Expereo.

“Having recently worked with Expereo on a global deployment for one of our customers, we witnessed first-hand the shared values of both companies and commitment to providing excellence in delivery and customer service. We are excited about joining the Expereo family and are certain that the global reach and scale of Expereo will be a benefit to all of our stakeholders,” says George Cowan, Managing Director of Breeze Networks.

The rapid adoption of cloud-based applications and SD-WAN technologies puts Internet-based WANs at the center of multinational companies’ business models. Expereo is committed to simplifying the sourcing and management of such network solutions, whilst ensuring exceptional customer experience to cater to the needs of its MSP partners and multinational clients.

About Breeze Networks Ltd
Breeze Networks is a privately owned UK based supplier of SD-WAN based Network and Security Managed Services. Established in 2016 the company has designed and deployed a significant number of SD-WAN based global and regional networks to our customers in both the private sector and UK government agencies. The Breeze team have developed extensive knowledge and experience of best of breed SD-WAN/SASE products which allows us to help our customers on their Cloud transformation journeys.

About Expereo
Expereo is a leading global provider of managed network solutions including, Global Internet, SD-WAN/SASE, and Enhanced Internet. With an extensive global reach, Expereo is the trusted partner of 30% of Fortune 500 companies. It powers enterprise and government sites in more than 190 countries, helping customers improve productivity and empowering their networks and cloud services with the agility, flexibility and value of the Internet, with optimal network performance.

Expereo was acquired by Vitruvian Partners in April 2021. The international growth capital and buyout firm acquired a majority shareholding in Expereo from leading European private equity firm Apax Partners SAS.

Sofia Pensado
sofia@grammatikagency.com

Posted on

Some 350 World Leaders From 157 Nations With Diplomatic Relations With North or South Korea Attended the August 11-15, Conference

International Leadership Summit Addresses Korean Reconciliation, Religious Freedom, and New Peace Alliances in Africa and the World

Washington, DC, Aug. 14, 2022 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASE

UPF International Leadership Summit Addresses Korean Reconciliation, Religious Freedom, and

New Peace Alliances in Africa and the World

Condolences Expressed for late Prime Minister Shinzo Abe

 International leaders at the Universal Peace Federation’s (UPF) Summit 2022 and Leadership Conference affirmed their support for global peacebuilding, especially on the Korean Peninsula. Sessions addressed the universal right to religious freedom and called for more education of youth in Africa.

Some 350 world leaders from the 157 nations with diplomatic relations with either North or South Korea attended the August 11-15, 2022, conference, either in person or virtually, at Jamsil Lotte Hotel in Seoul, to discuss “Toward Peace on the Korean Peninsula: Toward a World Culture of Peace.” In his welcoming remarks, UPF Chairman Thomas G. Walsh expressed hope that the focus and vision for peace on the Korean Peninsula could be taken to a broader level, and that “the divided world be reconciled into one humanity and one global culture of peace.”

In addition to calling for peace, the leaders expressed deep condolences for the loss of Japanese Prime Minister Shinzo Abe. UPF offered a video and floral tribute.

“My grandfather said the one thing people cannot go without is peace,” said Sheikh Mansour Diouf of the Murid Brotherhood in Senegal. “We are supposed to be brothers…” This sentiment was echoed by many of the religious leaders.

Korean reconciliation was a major theme, due to the passion of UPF co-founders, Rev. Dr. Sun Myung Moon and Dr. Hak Ja Han Moon, who were born in what is now North Korea. In 1991, anti-communist Rev. Moon went to Pyongyang to meet communist North Korea leader Kim Il-sung. The two men embraced as brothers and agreed to launch various projects together. That unity underscores the hope to bring peace to the 80 million people on the Korean Peninsula, despite decades of division, said Dr. Michael Jenkins, President, UPF International.

Along with the conference, UPF organized a Fact-Finding Delegation for Peace on the Korean Peninsula with US officials and South Korean leaders. Amb. Joseph DeTrani, Special Envoy to the Six-Party Talks with DPRK (2003-2006); Amb. Harry Harris, a US Navy admiral who served as US Ambassador to South Korea from 2018 to 2021; (Ret.) Gen. Walter Sharp, who led US forces, the UN Command, and ROK-US Combined Forces Command (2008-2011); and Dr. Alexandre Mansourov, Adjunct Professor at the Edmund Walsh School of Foreign Studies at Georgetown University, offered their assessments. (Full details will be available at UPF.org).

“Idealism must be rooted in realism,” said Amb. Harris. He praised South Korea President Suk-yeol Yoon for his intentions “to make the US-ROK Alliance the centerpiece of his foreign policy,” as that means outreach to Japan as well as military readiness.

Former US President Donald Trump, former Canadian Prime Minister Stephen Harper, Cambodia Prime Minister Samdech Hun Sen, Dr. Sok Siphana, head of Asian Vision Institute, and former Taiwan Vice President Lu Hsiu-lien offered remarks on the need to achieve peace.

Protecting religious freedom worldwide was another major theme. Religious freedom is “the most important single topic on the planet,” said US House Speaker Newt Gingrich (1995-1999). That is because it presupposes God’s existence and God’s bestowing rights to humanity, and this forms the basis of freedom, he explained.

Religious freedom is key to security concerns, added US Secretary of State Mike Pompeo (2018-2021), recalling that he always left his Bible open on his desk for inspiration. “Nations that threaten others, like China and Iran” also “have death holds” on religious freedoms, he noted.

From Japan, lawyer Norishige Kondo of the Family Federation for World Peace and Unification (FFWPU) talked about “a serious crisis of religious freedom in our country.” He spoke of the surreal situation of Japan’s media transferring blame for the brutal assassination of Prime Minister Abe from the shooter to FFWPU. He discussed human rights violations against 4,300 FFWPU members, while FFWPU member Toru Goto talked about his kidnapping, 12-year confinement, and lawsuits against perpetrators.

Hon. Jan Figel, Special Envoy for the Promotion of Freedom of Religion, European Union (2016-2019), noted that while 84% of the world population claims religious affiliation, 79% live in countries “with high or very high obstacles to religious freedom.” Religious prejudice generates three evils—”intolerance, discrimination, and persecution,” said Dr. Massimo Introvigne, Managing Director of the Center for Studies on New Religions in Italy.

A third major highlight was about strengthening peace and prosperity in Africa

The growing power of Africa—where the average age is 20—brings opportunities for education, jobs, encouraging peace, and protecting the environment, especially desertification. “It is imperative for us: We must train our youth so that they can resolutely take charge of their destiny,” said H.E. Brigi Rafini, Executive Secretary of the Community of Sahel and Saharan States (CEN-SAD) and former Prime Minister of Niger.

At an afternoon International Youth Leaders Conference, leaders from Malawi, Nigeria, Eswatini, Cape Verde, Somalia, DR Congo, and Niger discussed the importance of vocational training and character education for African youth. This was followed by the signing of an agreement to raise “youth for peace.”

In a separate session, Imboni Dr. Uzwi-Lezwe Radebe, founder of the Revelation Spiritual Home in South Africa, joined Most Rev. Daniel Okoh, President of the Christian Association of Nigeria; Hon. Issaka Sourwema, Minister of Religious and Customary Affairs of Burkina Faso; H.E. Rev. Nevers Mumba, Founder of the National Christian Coalition in Zambia; and Dr. Nokuzola Mndende, National Chairperson of the Council of African Religion in South Africa, to discuss a resolution to protect religious freedom in Africa. This resolution was subsequently signed.

Other highlights:

—The 40th Anniversary of The Washington Times. Chairman Thomas P. McDevitt, President and Executive Editor Christopher Dolan, and Opinion Editor Charles Hurt spoke of The Times’ impact and its dedication to accurate news and the ideals of freedom, faith, and family.

—The 60th Anniversary of The Little Angels. The world-famous children’s folk ballet company founded by Rev. and Mrs. Moon gave a beautiful special performance to the delight of conference participants.

—Visionary Sessions on Peace, Family, Science, Media, Higher Education, Youth, and Religion. The HJ Academic Foundation hosted more than 50 academicians for stimulating discussions on topics such as a Unity of Science movement, Character Education and the University in the Next 100 Years, the God Conference and Heavenly Parent’s Holy Community, the Women’s Movement and Family, and CEN-SAD Conference on Youth Education.

—Resolutions: Summit leaders signed the Resolution for a Universal Peace Charter; a Declaration on the Universal Value of Religious Freedom; a resolution to promote interfaith cooperation within Africa; and an agreement between the CEN-SAD, UPF, International Association of Youth and Students for Peace (IAYSP) and the Sunhak Educational Foundation to develop vocational training and character education for African youth.

—A special program to commemorate the 10th Anniversary of the passing of the Rev. Dr. Sun Myung Moon. North Korean Premier Kim Jong-un sent flowers and a personal message to Mrs. Moon, said UPF International Director-General Dr. Yun Young-ho.

— The 5th THINK TANK 2022 Forum. Experts gathered to discuss concrete ideas on how to achieve reconciliation on the Korean Peninsula. The forum will be broadcast at a future date.

Among the more than 100 distinguished speakers were: Senegal President Macky Sall; H.E. Muhammadu Buhari, President, Nigeria; Hon. Mike Pence, US Vice President (2017-2021); Hon. Dan Burton, US Member of Congress (1983-2013); Beeland Interests Chairman Jim Rogers; Pastor Paula White-Cain, City of Destiny Church; Bishop Don Meares, the Evangel Cathedral; Hee-Taek Chung, President of the Segye Ilbo newspaper; H.E. Boris Tadic, President (2004-2012), Serbia; H.E. Yves Leterme, Prime Minister (2008, 2009-2011), Belgium; H.E. Ehud Olmert, Prime Minister (2006-2009), Israel; Hon. Neziha Labidi, Minister of Women, Family & Children (2016-2020), Tunisia; Hon. German Blanco Alvarez, Senator, Colombia; Hon. Grigore Novac, Member of Parliament, Moldova; Hon. Prof. Sunaina Singh, Vice Chancellor, Nalanda University, India; Mme. Adi Koila Nailatikau, First Lady (2009-2015), Fiji; H.E. Johnson Toribiong, President (2009-2013), Palau; Hon. Patricia Terrazas Baca, Member of Parliament, Mexico; Dr. Ann Higgins, President, World Dance Congress, Bahamas; Hon. Dave Laksono, Member of Parliament, Indonesia; Hon. Ross Robertson, Member of Parliament (1987-2014), New Zealand; and H.E. Jose Manuel Barroso, President, European Commission, (2004-2014).


For media inquiries:

William P. Selig
Communications Director
Universal Peace Federation
Ph: 240-274-1744
Email: wselig@upf.org
www.UPF.org

Attachment

William P. Selig

Universal Peace Federation

240-274-1744 wselig@upf.org
Posted on

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM

NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) —

WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) between September 15, 2020 and June 13, 2022, both dates inclusive (the “Class Period”), of the important September 6, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Outset Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Outset Medical class action, go to https://rosenlegal.com/submit-form/?case_id=6976 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 6, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) defendants had “continuously made improvements and updates to Tablo over time since its original clearance” that required an additional 510(k) application; (2) as a result, Outset Medical could not conduct a human factors study on a cleared device in accordance with FDA protocols; (3) Outset Medical’s inability to conduct the human factors study subjected Outset Medical to the likelihood of the FDA imposing a “shipment hold” and marketing suspension, leaving the Company unable to sell Tablo for home use; and (4) as a result, defendants’ positive statements about Outset Medical’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Outset Medical class action, go to https://rosenlegal.com/submit-form/?case_id=6976 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

Posted on

Insilico Medicine Announces New Investment Led by Aramco-backed Prosperity7 Ventures, bringing total Series D Financing to $95 Million

New York, Aug. 10, 2022 (GLOBE NEWSWIRE) — HIGHLIGHTS:

●      Insilico Medicine announces a closing of its Series D2 round, bringing the total Series D financing to $95 million, despite an uncertain market

●       The Series D2 round is led by Prosperity7, the diversified growth fund of Aramco Ventures, which is an investment subsidiary of Aramco, the world’s leading integrated energy and chemicals company

●    Relying on Prosperity7’s global network and generous resources, Insilico will expand its AI capabilities from drug R&D to multiple areas to support sustainable development

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a second closing of its Series D round, led by Prosperity7 Ventures, the diversified growth fund of Aramco Ventures, bringing the total Series D financing to $95 million. Other global investors with expertise in the biopharmaceutical and life sciences sectors also participated.

The financing brought in Prosperity7 as a new investor, alongside current investors in the Series D round, including a large, diversified asset management firm on the US West Coast, B Capital Group, Warburg Pincus, BHR Partners, Qiming Venture Partners, Deerfield, Pavilion Capital, BOLD Capital Partners, and WS Investment Company. Insilico’s founder and CEO, Alex Zhavoronkov, PhD, also invested in the Series D round.

Aysar Tayeb, Executive Managing Director of Prosperity7 Ventures, said: “The deepening application of AI and machine learning for drug discovery has demonstrated a transformative positive impact on the pharmaceutical industry and we are delighted to embark on this partnership with Insilico Medicine, a frontrunner in this innovation. Backed by the breadth of Aramco’s ecosystem across geographies and sectors, we look to support the company to scale up and expand its footprint globally, to drive biotechnology excellence, and to bring positive impact for greater wellbeing.”

The new Series D capital will support the continued advancement of Insilico’s pipeline, including its lead program which is currently in a Phase 1 study in New Zealand and in China, as well as several pipeline programs in IND-enabling studies. The proceeds will also fund other key strategic initiatives, including further development of its end-to-end Pharma.AI platform, the launch of a fully automated, AI-driven robotic drug discovery laboratory and biological data factory, and the establishment of regional centers.

The investment from Prosperity7 further diversifies the Company’s investor base globally and brings a potential strategic partner with deep expertise in high-performance and environmentally friendly energy R&D. Relying on Prosperity7’s global network and generous resources, Insilico will expand its AI capabilities from drug R&D to multiple areas, including sustainable chemistry, green energy, and agriculture to actively support sustainable development. Insilico had already leveraged the power of its platform to accelerate innovation in sustainable agriculture in a multi-year collaboration with Syngenta which validated that the platform’s capabilities in AI-enabled multiparameter optimization could create substantial value.

“In 2022, Aramco became the world’s most valuable company, and we are deeply honored to receive the investment from their venture capital arm, Prosperity7, which focuses on investment in ‘disruptive technology’,” said Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine. “Our experience in expanding our reach into sustainable agriculture through our collaboration with Syngenta and others demonstrated the diversity of data and methods and unprecedented scale up allows us to improve our performance. I am certain that the collaborations with Prosperity7 in the field of sustainable and environmentally friendly chemistry and clean energy solutions will further expand our artificial intelligence capabilities. In addition, after spending time in Saudi Arabia, it is clear that the country is making a giant leap in technology. We would love to be part of this effort and help the country realize its vision using the latest advances in artificial intelligence.”

Through a unique dual-CEO structure, Insilico Medicine is advancing its AI capabilities and drug research and development simultaneously. Recently, the Company promoted Dr. Feng Ren, Insilico’s Chief Scientific Officer (CSO) to the position of co-CEO to drive the company’s drug R&D platform. In addition to overseeing drug discovery and development, Dr. Ren will also guide the Company’s growing clinical development and will play a leading role in driving business development. During his tenure, the Company has rapidly transformed its pipeline into a robust portfolio of novel, innovative drug candidates, targeting areas with highly unmet needs. Seven programs in its internal pipeline have progressed to IND-enabling studies, including a novel 3CL protease inhibitor for COVID-19 treatment, and two synthetic lethality programs targeting MAT2A and USP1 for oncology indications. It also successfully completed a Phase 0 microdose study in Australia and entered Phase I clinical trials with its first internally developed program targeting fibrosis in both New Zealand and China.

“We have the structure to be as an equal parts AI and drug development company,” said Feng Ren, PhD, co-CEO and CSO of Insilico Medicine. “We also have a number of exciting initiatives in motion – including an expanding global presence, a robotics lab in development, and significant progress in our internal pipeline programs. With this latest funding round, we will be able to scale up our capabilities, advance our internal programs, develop our AI, and align with partners in the Saudi region to develop new regional technology hubs.”

Insilico has co-development and software licensing deals with a number of major pharmaceutical companies. Since the launch of its PandaOmics™ and Chemistry42™ platforms in late 2020, nine out of the top 20 pharmaceutical companies, as measured by 2020 revenue, have used Insilico’s AI platforms. In 2022, Insilico signed multi-asset partnerships with Fosun Pharma and EQRX in January and March, respectively. Notably, Insilico achieved its first major milestone and nominated a preclinical candidate for the QPCTL program for cancer immunotherapy less than 40 days into the strategic collaboration with Fosun Pharma.  Business development continues to remain a vital part of the company’s strategy to demonstrate and unlock the value of its Pharma.AI platform.

About Insilico Medicine

Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques to discover novel targets and to design novel molecular structures with desired properties. Insilico Medicine is delivering breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases and aging-related diseases.

For more information, visit www.insilico.com

For media inquiries, please contact media@insilicomedicine.com

About Prosperity7 Ventures

Prosperity7 Ventures is the diversified growth fund of Aramco Ventures, a subsidiary of Aramco, the world’s leading integrated energy and chemicals company. The fund’s name is derived from ‘Prosperity Well’, the 7th oil well drilled in Saudi Arabia and the first to strike oil. Taking forward this pioneering history, we invest globally, with a long term-view, in breakthrough technologies and transformational business models that will bring prosperity and positive impact on a vast scale.

For more information, visit www.prosperity7vc.com

Brita Belli
Insilico Medicine
475-225-0843
brita@insilico.com
Posted on

OKX and LinkedIn Co-author Global Blockchain Industry Talent Report

  • The supply and demand of talent in the global blockchain field are out of balance, with candidates in short supply
  • The demand for core talent has shifted from financial-oriented to technical focused
  • The average tenure of global blockchain talents is 1.2 years, the turnover rate is high, and the flow of talent is mainly within the blockchain industry

VICTORIA, Seychelles, Aug. 10, 2022 (GLOBE NEWSWIRE) — OKX, the world-leading cryptocurrency platform and LinkedIn, the world’s largest professional network, have co-authored a report that highlights the imbalance between the supply and demand of qualified talent in the global blockchain industry.

The in-depth research, based on LinkedIn’s exclusive big data analysis, took data from 180 countries in the period between January 2019 and June 2022. It covers the blockchain sector, as well as sub-industries that include the cryptography, quantum computing and distributed ledger sectors, as well as more than 15 other related sub-industries.

The report reveals that, as of June 2022, the supply and demand of talent in the global blockchain field are out of balance, with qualified candidates in short supply. The total number of LinkedIn members working in the blockchain field has increased by 76% year-on-year, but the major countries that blockchain sector candidates have traditionally come from are experiencing negative talent growth. China, where growth is stable, is the exception to this trend.

Haider Rafique, Chief Marketing Officer, OKX, said: “The results of the study we have conducted with LinkedIn reflect our own ongoing search for great talent at OKX. We announced previously that we were going to increase our headcount by 30% by the end of next year and this remains true. I am confident that OKX’s leadership among crypto exchanges, our determination to constantly innovate and improve the user experience, and our certainty that blockchain and Web 3.0 is the future will allow us to continue to attract the best talent.”

The research also shows that the demand for core talent has shifted from financial-oriented to candidates with technical skills. In terms of number of job postings, R&D specialists top the global demand, followed by information technology. Product management, marketing and human resources job offerings are not far behind. From the perspective of recruitment demand, financial candidates are now ranked in the sixth position.

Another challenge highlighted by the report involves the short tenure of candidates and the high turnover rate. The ‘LinkedIn Global Talent Big Data Insights’ report shows that the average tenure of global blockchain talent is 1.2 years. The report also shows that in addition to the influx of talent from traditional financial and technology companies, talent movement in the global blockchain industry is mainly based on intra-industry flow.

Linda Tse, Global Talent Acquisition Lead, OKX said: “As a booming frontier industry that is affected by the talent trends of the entire blockchain sector, the competition for high-quality candidates and the frequent movement of talent is somewhat inevitable. That being said, OKX’s strong focus on innovation, professional development, work-life balance and our mission-driven mindset are supporting our talent growth strategy. We received almost 19,000 job applications in May of 2022, and this number has only kept on increasing”

The full OKX/LinkedIn Global Blockchain Industry Talent Report can be found at OKX.com and on LinkedIn.

For further information, please contact:
Media@okx.com

About OKX
OKX is a leading crypto trading app, and a Web3 ecosystem. Trusted by more than 20 million global customers in over 180 international markets, OKX is known for being the fastest and most reliable crypto trading app of choice for investors and professional traders globally.

To learn more about OKX, download our app or visit: okx.com

Posted on

Lakemore Partners Appoints Paul Gyra as Chair of Audit Committee

PHOENIX and LONDON and DUBAI, United Arab Emirates, Aug. 10, 2022 (GLOBE NEWSWIRE) — Lakemore Partners Ltd. and its group entities (“Lakemore”), a leading private credit investment firm primarily investing in control CLO equity, today announced it has appointed Paul Gyra as the independent Chair of the Lakemore Partners Audit Committee. Mr. Gyra is a seasoned business executive with over three decades of experience in investment banking and asset management.

“We are thrilled to have appointed Paul as Chair of our Audit Committee,” said Ahmed Farid, Chairman and President of Lakemore. “Paul’s deep understanding of our firm’s culture and years of expertise spearheading cross-border strategies will serve Lakemore well as we further establish and maintain longstanding partnerships with our clients and top-tier CLO collateral managers across the world.”

In addition to his roles at Lakemore, Mr. Gyra also serves as Managing Partner at the Thompson Family Office, where he helps to execute on the development of Smart, Sustainable City outside of Washington, DC, and development of direct investment programs with like-minded Family Office Partners that have a social and environmental impact. Previously, Mr. Gyra served as Managing Partner at Global Investment Bank Limited, where he was responsible for cross-border transactions and business development. Prior to that, Mr. Gyra was the Chief Operating Officer, Head of Strategy and Managing Partner at Safanad Limited, where he was responsible for the principal investment firm’s business operations and strategy across its Dubai, New York and London offices. Mr. Gyra also held CEO positions at ING Alternative Asset Management in New York, and Baring Asset Management – North America.

“I am confident that my familiarity with the firm will serve me well in this new role,” said Mr. Gyra. “I look forward to continuing to work closely with the team and Board to provide Lakemore’s global clientele of institutional investors with best-in-class service.”

Mr. Gyra is a CPA and received his BS Summa Cum Laude from Providence College, and attended the Advanced Management Program at Harvard Business School.

About Lakemore Partners

Lakemore is a leading private credit investment firm primarily investing in control CLO equity. Serving as a partner of choice for global top-tier collateral managers in the CLO market who are aligned to the firm’s portfolio management style and risk appetite, Lakemore aims to deliver attractive returns by leveraging the extensive expertise of its dedicated team and by investing within its well-defined framework of cycle-aligned risk allocation. Founded in 2016, Lakemore has offices in Phoenix, London and Dubai. Lakemore’s mission focuses on providing sustainable and reliable income, with the firm currently managing US$1.3 billion in credit assets under management, the majority of which is from institutional clients. For more information, please visit www.lakemore.com.

Lakemore Partners Ltd. is the group parent and is domiciled in the Cayman Islands. Lakemore Partners Management US LLC and Lakemore Partners (UK) Ltd. are registered with the U.S. Securities & Exchange Commission as investment advisers (RIA). Lakemore Partners (UK) Ltd. (FRN: 837603) is also an appointed representative of Kroll Securities Ltd. (FRN: 466588), which is authorized and regulated by the Financial Conduct Authority. Lakemore Partners (DIFC) Ltd. is regulated by the Dubai Financial Services Authority. Lakemore Partners Management US LLC, Lakemore Partners (UK) Ltd., and Lakemore Partners (DIFC) Ltd. are wholly owned subsidiaries of Lakemore Partners Ltd.

Media contacts:
Doug Allen/Josh Gerth
Dukas Linden Public Relations
lakemore@dlpr.com
+1 (646) 722-6530

Posted on

Konstantinos Fakiolas Named Business Development Manager for Nikkiso Clean Energy and Industrial Gases Group Europe

TEMECULA, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Konstantinos Fakiolas has been named Business Development Manager for the Group’s Cryogenic Pumps Unit.

Kostas is a Naval Architect & Marine Engineer, MSc, MBA, graduate from the National Technical University of Athens Greece, with 24 years of specialization in ship technological applications involving LNG systems, environmental technologies, renewables and energy efficiency.

He has been working closely with Technology providers for their marine business development, while extensively engaged with Asian Shipyards for new building and existing ship upgrade contract negotiations and project management.

Throughout his career he has been occupied as a ship designer, ship surveyor for flag administrations, newbuilding field supervisor, newbuilding contracts project manager, international sales director and business development partner for technology providers acting on global scale.

In this role, he will be managing and implementing a global business development strategy toward growing and expanding Nikkiso Clean Energy products portfolio, solutions and services in the marine market segment. This strategy includes increasing competitiveness and applicability in marine projects, product development and management, and strategic collaboration with industrial partners. Kostas will be based in Europe and will be reporting directly to Mike Wells, Technical Sales Manager, Business Development, Nikkiso Clean Energy & Industrial Gases Group Pumps Unit.

“Konstantinos’ extensive experience, contacts, industry and market knowledge will be instrumental in developing new opportunities in the Marine market and better serving our customers,” according to Ole Jensen, Vice President, NCEIG Europe.

With this addition, Nikkiso continues their commitment to be both a global and local presence for their customers.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture and service engineered cryogenic gas processing equipment (pumps, turboexpanders, heat exchangers, etc.), and process plants for Industrial Gases, Natural gas Liquefaction (LNG), Hydrogen Liquefaction (LH2) and Organic Rankine Cycle for Waste Heat Recovery. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Nikkiso Cryo, Nikkiso Integrated Cryogenic Solutions, Cosmodyne and Cryoquip and a commonly controlled group of approximately 20 operating entities.

For more information, please visit www.NikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

Posted on

LeddarTech Brings Raw Data Fusion and Perception Technology to Automotive ADAS and AD Events in China and the U.S.

QUEBEC CITY, Aug. 10, 2022 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce a series of events in China and the United States focused on demonstrating their newest technology, LeddarVision™, a unique raw data fusion and perception solution.

LeddarTech’s use of raw data fusion detects very small obstacles on the road with better detection rates and fewer false alarms than legacy “object fusion” solutions. In addition, unclassified obstacles are also detected, providing an additional layer of safety to the vehicle.

LeddarVision is a flexible, robust, cost-effective, sensor-agnostic and scalable auto-grade solution that delivers highly accurate 3D environmental models. In addition, the software supports all SAE autonomy levels by applying AI and computer vision algorithms to fuse raw data from sensors employed in L2-L5 applications.

12th New Energy Vehicle International Forum 2022 – August 18-19 – Suzhou, China

The 12th edition of this conference and exhibition on new vehicle technologies and design brings together hundreds of VIPs and high-quality industry participants from 15+ countries and 50+ esteemed speakers.

LeddarTech presents “Solving Key ADAS/AD Perception Challenges — Raw Data Fusion and Perception Technology.”

When: August 18, 2022, 12:00-12:30 CST (China standard time).

Where: Shangri-La Hotel, Suzhou, China.

Register here.

ADAS & Autonomous Vehicle Technology Expo and Conference – September 7-8 – San Jose, USA

This new ADAS & AV tech expo features products and solutions for developing and building next-generation connected and fully autonomous vehicles.

LeddarVision showcase (booth #1052): Engineers from Israel and North America will demonstrate how raw data fusion technology simplifies complex sensor sets and eliminates the dependency on hardware to provide customers the flexibility to scale and deliver greater ADAS and AD performance quickly.

When: September 7-8, 2022.

Where: San Jose McEnery Convention Center, San Jose, USA.

Booth: 1052

Register here.

Visit here to learn where else LeddarTech is in the world.

About LeddarTech

Founded in 2007, LeddarTech is a comprehensive end-to-end environmental sensing company that enables customers to solve critical sensing, fusion and perception challenges across the entire value chain. LeddarTech provides cost-effective perception solutions scalable from Level 2 ADAS to Level 5 full autonomy with LeddarVision™, a raw-data sensor fusion and perception platform that generates a comprehensive 3D environmental model from a variety of sensor types and configurations. LeddarTech also supports LiDAR manufacturers and Tier 1-2 automotive suppliers with key technology building blocks such as LeddarSteer™ digital beam steering and the LeddarEngine™, which is built on LeddarTech’s Leddar™ technology employing patented signal acquisition and processing techniques to generate a richer and cleaner return signal at a lower cost. The LeddarEngine comprises a highly integrated, scalable LiDAR SoC and software combination that enables LiDAR developers and Tier 1-2 automotive suppliers to design their own LiDAR solutions. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 120 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@leddartech.com

Investor relations contact: InvestorRelations@leddartech.com
https://investors.leddartech.com/

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, LeddarEcho, VAYADrive, VayaVision, XLRator and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.